Ursodiol
Rank #368 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$26.6M
Total Cost
123,719
Total Claims
$26.6M
Total Cost
4,552
Prescribers
$215
Cost per Claim
14,139
Beneficiaries
211,785
30-Day Fills
$5,842
Avg Cost/Provider
27
Avg Claims/Provider
Share of Medicare Part D Spending
0.01%
of total Medicare Part D spending
$26.6M of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $26.6M total
Top Prescribers of Ursodiol
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | Dae Rheem | Gastroenterology | Los Angeles, CA | 1,305 | $345K |
| 2 | Lael Forbes | General Surgery | New York, NY | 54 | $239K |
| 3 | Naim Alkhouri | Internal Medicine | San Antonio, TX | 138 | $138K |
| 4 | Sing Chan | Gastroenterology | Flushing, NY | 50 | $119K |
| 5 | Jeffrey Crippin | Gastroenterology | Saint Louis, MO | 477 | $114K |
| 6 | Viplove Senadhi | Gastroenterology | Montgomery, AL | 28 | $113K |
| 7 | Hector Ye | Physician Assistant | Flushing, NY | 325 | $103K |
| 8 | Rachel Thomas | Nurse Practitioner | Chattanooga, TN | 340 | $103K |
| 9 | M Ayasso | Gastroenterology | Pittsburgh, PA | 302 | $96K |
| 10 | Viplove Senadhi | Gastroenterology | Montgomery, AL | 71 | $96K |
| 11 | Ann Moore | Nurse Practitioner | Glendale, AZ | 68 | $83K |
| 12 | Irving Ingraham | Gastroenterology | Peabody, MA | 458 | $82K |
| 13 | Kapil Chopra | Gastroenterology | Pittsburgh, PA | 225 | $79K |
| 14 | Hector Nazario | Gastroenterology | Dallas, TX | 357 | $79K |
| 15 | Enrique Martinez | Gastroenterology | Atlanta, GA | 303 | $79K |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 365 | Lisinopril/Hydrochlorothiazide (Lisinopril-Hydrochlorothiazide) | $26.8M | 2,304,445 |
| 366 | Dofetilide (Dofetilide) | $26.7M | 98,814 |
| 367 | Plecanatide (Trulance) | $26.6M | 36,026 |
| 368 | Ursodiol (Ursodiol) | $26.6M | 123,719 |
| 369 | Glycerol Phenylbutyrate (Ravicti) | $26.6M | 268 |
| 370 | Doravirine (Pifeltro) | $26.4M | 14,437 |
| 371 | Brinzolamide/Brimonidine Tart (Simbrinza) | $26.3M | 97,240 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology